Literature DB >> 7544385

A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats.

J A Stepaniak1, K E Gould, D Sun, R H Swanborg.   

Abstract

We compared the T cell responses of Lewis (LEW) and DA rats to guinea pig myelin basic protein (MBP), the synthetic peptides corresponding to the epitopes that are encephalitogenic in the LEW strain (MBP73-86, MBP68-86, and MBP87-99), and bovine proteolipid protein (PLP). DA and LEW rats were susceptible to experimental autoimmune encephalomyelitis (EAE) induced with MBP or MBP68-86, but the peptide was less active in DA rats than in intact MBP molecule. MBP73-86 and MBP87-99 induced EAE in LEW rats but not in the DA strain. MBP89-169 was also encephalitogenic in DA rats. Encephalitogenic CDa+ T cell lines and clones derived from MBP-sensitized DA rats secreted IFN-gamma and TNF-alpha and proliferated to MBP and MBP89-169, but not to MBP68-88. However, T cells from MBP68-86-sensitized DA or LEW rats proliferated specifically in an I-A-restricted response to MBP68-86. T cells from MBP87-99-immunized LEW rats responded to MBP87-99 in the context of I-E, whereas the peptide-specific response of MBP87-99 immunized DA rats was I-A-restricted, although FACScan analysis indicated that DA rats express both I-A and I-E. DA rats were also highly susceptible to EAE induced with PLP; 0.6 nmol was Encephalitogenic for DA rats, but did not induce clinical EAE in LEW rats. Although both DA and LEW rats are highly susceptible to EAE, we demonstrate marked differences in the array of myelin epitopes capable of inducing the disease, as well as the MHC restriction of these epitopes, between the two rat strains.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544385

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Strain-Related Differences in the Immune Response: Relevance to Human Stroke.

Authors:  Kyra J Becker
Journal:  Transl Stroke Res       Date:  2016-02-10       Impact factor: 6.829

Review 2.  Systemic immunomodulation of autoimmune disease using MHC-derived recombinant TCR ligands.

Authors:  Gregory G Burrows
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2005-04

3.  Research on the mechanism of Zuogui Pill and Yougui Pill in promoting axonal regeneration in model rats of autoimmune encephalomyelitis.

Authors:  Lei Wang; Hui Zhao; Yong-ping Fan; Hai-yang Gong; Ming Li; Fang Qi; Yan Liu
Journal:  Chin J Integr Med       Date:  2010-05-16       Impact factor: 1.978

4.  The biochemical and morphological alterations following administration of melatonin, retinoic acid and Nigella sativa in mammary carcinoma: an animal model.

Authors:  Mohamad A Abd el-Aziz; Hosny A Hassan; Mahmoud H Mohamed; Abdel-Raheim M A Meki; Sary K H Abdel-Ghaffar; Mahmoud R Hussein
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

5.  MHC haplotype-dependent regulation of MOG-induced EAE in rats.

Authors:  R Weissert; E Wallström; M K Storch; A Stefferl; J Lorentzen; H Lassmann; C Linington; T Olsson
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

6.  Complexities of applying nasal tolerance induction as a therapy for ongoing relapsing experimental autoimmune encephalomyelitis (EAE) in DA rats.

Authors:  X F Bai; H L Li; F D Shi; J Q Liu; B G Xiao; P H Van der Meide; H Link
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  Altered peptide ligands of myelin basic protein ( MBP87-99 ) conjugated to reduced mannan modulate immune responses in mice.

Authors:  Maria Katsara; Elizabeth Yuriev; Paul A Ramsland; Theodore Tselios; George Deraos; Athanasios Lourbopoulos; Nikolaos Grigoriadis; John Matsoukas; Vasso Apostolopoulos
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

Review 8.  Role of viruses in etiology and pathogenesis of multiple sclerosis.

Authors:  S S Soldan; S Jacobson
Journal:  Adv Virus Res       Date:  2001       Impact factor: 9.937

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.